Reported 17,100 shares, unchanged from the prior quarter.
Reported value 18.4%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 77918000 |
| 2022-03-31 | 45990000 |
| 2022-06-30 | 38060000 |
| 2022-09-30 | 28849000 |
| 2022-12-31 | 27501130 |
| 2023-03-31 | 22193091 |
| 2023-06-30 | 37277681 |
| 2023-09-30 | 1157823 |
| 2023-12-31 | 874428 |
| 2024-03-31 | 909636 |
| 2024-06-30 | 452918 |
| 2024-09-30 | 403100 |
| 2024-12-31 | 331900 |
| 2025-03-31 | 174165 |
| 2025-06-30 | 0 |
| 2026-06-30 | 40014 |
| 2026-09-30 | 47367 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 17,100 | 0 (0.0%) | < 0.01% | $47,367 | 2026-11-16 | |
| Q2 2026 | New | 17,100 | +17,100 (0.0%) | < 0.01% | $40,014 | 2026-08-14 | |
| Q2 2025 | Reduced | 0 | -109,538 (-100.0%) | 0 | $0 | 2025-08-14 | |
| Q1 2025 | Unchanged | 109,538 | 0 (0.0%) | < 0.01% | $174,165 | 2025-05-15 | |
| Q4 2024 | Unchanged | 109,538 | 0 (0.0%) | < 0.01% | $331,900 | 2025-02-12 | |
| Q3 2024 | Reduced | 109,538 | -1,200 (-1.1%) | < 0.01% | $403,100 | 2024-11-14 | |
| Q2 2024 | Added | 110,738 | +53,020 (91.9%) | < 0.01% | $452,918 | 2024-08-14 | |
| Q1 2024 | Unchanged | 57,718 | 0 (0.0%) | < 0.01% | $909,636 | 2024-05-14 | |
| Q4 2023 | Unchanged | 57,718 | 0 (0.0%) | < 0.01% | $874,428 | 2024-02-14 | |
| Q3 2023 | Reduced | 57,718 | -1,263,717 (-95.6%) | < 0.01% | $1,157,823 | 2023-11-14 | |
| Q2 2023 | Added | 1,321,435 | +31,139 (2.4%) | 0.02% | $37,277,681 | 2023-08-15 | |
| Q1 2023 | Reduced | 1,290,296 | -75,202 (-5.5%) | < 0.01% | $22,193,091 | 2023-05-15 | |
| Q4 2022 | Added | 1,365,498 | +33,614 (2.5%) | 0.01% | $27,501,130 | 2023-02-15 | |
| Q3 2022 | Reduced | 1,331,884 | -22,579 (-1.7%) | 0.01% | $28,849,000 | 2022-11-15 | |
| Q2 2022 | Added | 1,354,463 | +357,704 (35.9%) | 0.02% | $38,060,000 | 2022-08-15 | |
| Q1 2022 | Added | 996,759 | +69,822 (7.5%) | 0.02% | $45,990,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 926,937 | -59,016 (-6.0%) | 0.03% | $77,918,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
140 managers reported ZENTALIS PHARMACEUTICALS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Squadron Capital Management LLC | Added | 6,827,905 | +3,127,905 | 4.75% | $18,913,297 | 3 qtrs |
| CITADEL ADVISORS LLC | Added | 4,489,717 | +2,191,314 | < 0.01% | $12,436,516 | 26 qtrs |
| 5AM Venture Management LLC | Unchanged | 3,947,913 | 0 | 3.68% | $10,935,719 | 14 qtrs |
| BlackRock Inc | Added | 3,912,620 | +159,095 | < 0.01% | $10,837,956 | 9 qtrs |
| ADAR1 Capital Management LLC | Added | 3,762,532 | +3,109,782 | 0.44% | $10,422,214 | 6 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 3,523,514 | +687,845 | < 0.01% | $9,760,134 | 3 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Added | 3,056,124 | +374,224 | < 0.01% | $8,455,000 | 9 qtrs |
| TWO SIGMA INVESTMENTS LP | Reduced | 2,801,386 | -223,550 | < 0.01% | $7,759,839 | 14 qtrs |
| Patient Square Capital LP | New | 2,007,485 | +2,007,485 | 0.89% | $5,560,733 | 1 qtr |
| Seven Fleet Capital Management LP | Added | 1,504,231 | +1,186,631 | 0.81% | $4,166,720 | 3 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 17,100
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.